February 2, 2025 - 23:03

Recent actions by the Centers for Disease Control and Prevention (CDC) have led to the removal of various websites and datasets that focused on critical health issues, including HIV, LGBTQ health, and youth health behaviors. This decision comes in response to directives from the Trump administration aimed at streamlining federal health data.
Epidemiologist Dr. Jennifer Nuzzo has voiced significant concerns regarding the implications of this data removal. She argues that the absence of comprehensive health information could hinder public health efforts, particularly for marginalized communities that rely on these resources for support and guidance. The loss of data on HIV and LGBTQ health is particularly alarming, as it may impede ongoing efforts to address health disparities and inform effective interventions.
Dr. Nuzzo emphasizes that accurate and accessible health data is vital for understanding and addressing the needs of diverse populations. The removal of these resources could ultimately lead to a gap in knowledge that may affect policy decisions and public health strategies moving forward.
May 9, 2026 - 22:43
College of Pharmacy & Health Sciences confers 206 degrees - NewsThe Campbell University College of Pharmacy & Health Sciences held its spring commencement ceremony to honor the achievements of the Class of 2026. A total of 206 degrees were conferred during the...
May 9, 2026 - 02:40
California Becomes First State to Offer Free Diapers for Every NewbornCalifornia is set to launch a first-of-its-kind program that will provide free diapers to every newborn in the state. The initiative, which makes California the first state in the country to offer...
May 8, 2026 - 11:45
Maryland ranked high among states for public health preparedness, but could be doing moreMaryland continues to rank among the top states in the nation for its ability to handle public health emergencies, according to a recent analysis by a national health policy organization. The state...
May 7, 2026 - 18:47
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo NordiskThe arrival of the first generic versions of semaglutide in Canada is being watched closely as a potential turning point for Novo Nordisk`s dominance in the global weight-loss and diabetes market....